ARCHIVES

ODAC Rejects Amsacrine NDA, Renews Idarubicin

This article is from The Cancer Letter archive.

Vol. 16 No. 35 | September 14, 1990

Download PDF Visit The Full Archive

Related Articles

BSA Approves Provocative Questions RFA; NCI Announces Review of SAIC-Frederick, for caBIG Restructuring

June 24, 2011

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

White House Gives FDA Authority Over Tobacco Product Sales

August 18, 1995

ETP-ALL May Be Linked To Acute Myeloid Leukemia

January 27, 2012

FCRF Contracts Hit $40.3 Million With Transfer Of Labs From NIH, Elsewhere

October 8, 1982

Monroe Wall, Co-Discoverer Of Taxol, Camptothecin, Dead At 85

July 12, 2002